Sharechat Logo

Tony Falkenstein to pump $400,000 into IRG

Thursday 3rd September 2009

Text too small?

Tony Falkenstein’s Edwin Trust has offered to inject capital into Investment Research Group, helping strengthen the balance sheet two weeks after the investment advisory and brokerage group gained a waiver from its banks over a covenant breach.  

The trust, which is associated with the Just Water International chief executive, will buy some 17.8 million shares at 2.25 cents apiece in IRG for $400,000. The deal is subject to shareholder approval and a vote will be held at next month’s annual meeting.  

“We have previously announced that we had intended to raise further capital and we are pleased to advise that an agreement has been reached with the Edwin Trust,” managing director Brent King said in a statement.

“We have made very good progress with the group over the last two months and we are now well positioned to take advantage of the opportunities to grow the business.” 

Last month IRG signed a letter of offer with its bank to confirm ongoing funding support. IRG was suspended from trading on the NZAX market on August 11 for a late filing of its annual report. It resumed trading this week.  

The shares, which trade infrequently, slumped 61% to 1.1 cents on the exchange yesterday.  

Businesswire.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors